Managing inflammation after spinal cord injury through manipulation of macrophage function

Neural Plasticity

Volumn 2013, Issue , 2013, Pages

  Ren, Yi ^a   Young, Wise ^b  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ATORVASTATIN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; COLONY STIMULATING FACTOR 1; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIVER X RECEPTOR; METHYLPREDNISOLONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROSTAGLANDIN J2; ROSIGLITAZONE; SMALL INTERFERING RNA;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL DIFFERENTIATION; CELL POLARITY; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; HUMAN; IN VIVO STUDY; INFLAMMATION; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MANIPULATIVE MEDICINE; MESENCHYMAL STEM CELL TRANSPLANTATION; MONOCYTE; MYELITIS; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; REGULATORY MECHANISM; SPINAL CORD INJURY; THERAPY EFFECT; UPREGULATION; DRUG EFFECT; MACROPHAGE; NEUTROPHIL CHEMOTAXIS; REVIEW; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; HUMANS; INFLAMMATION; MACROPHAGES; MONOCYTES; NEUTROPHIL INFILTRATION; PHENOTYPE; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES;

EID: 84889030920     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2013/945034     Document Type: Article

References (111)

1. Fleming J. C., Norenberg M. D., Ramsay D. A., Dekaban G. A., Marcillo A. E., Saenz A. D., Pasquale-Styles M., Dietrich W. D., Weaver L. C., The cellular inflammatory response in human spinal cords after injury. Brain 2006 129 12 3249 3269 2-s2.0-33845332735 10.1093/brain/awl296 (Pubitemid 44871440)
2. Murray P. J., Wynn T. A., Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology 2011 11 11 723 737 2-s2.0-80355131976 10.1038/nri3073
3. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M., The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology 2004 25 12 677 686 2-s2.0-7644231561 10.1016/j.it.2004.09. 015 (Pubitemid 39457982)
4. Gordon S., Taylor P. R., Monocyte and macrophage heterogeneity. Nature Reviews Immunology 2005 5 12 953 964 2-s2.0-28544446111 10.1038/nri1733 (Pubitemid 41746764)
5. Bellora F., Castriconi R., Dondero A., Reggiardo G., Moretta L., Mantovani A., Moretta A., Bottino C., The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proceedings of the National Academy of Sciences of the United States of America 2010 107 50 21659 21664 2-s2.0-78650742405 10.1073/pnas.1007654108
6. Shechter R., Miller O., Yovel G., Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 2013 38 555 569
7. Kigerl K. A., Gensel J. C., Ankeny D. P., Alexander J. K., Donnelly D. J., Popovich P. G., Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. The Journal of Neuroscience 2009 29 43 13435 13444 2-s2.0-70350558453 10.1523/JNEUROSCI.3257-09.2009
8. Dalli J., Serhan C. N., Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 2012 120 e60 e72
9. Liu N.-K., Xu X.-M., Phospholipase A2 and its molecular mechanism after spinal cord injury. Molecular Neurobiology 2010 41 2-3 197 205 2-s2.0-77955086151 10.1007/s12035-010-8101-0
10. Buczynski M. W., Svensson C. I., Dumlao D. S., Fitzsimmons B. L., Shim J.-H., Scherbart T. J., Jacobsen F. E., Hua X.-Y., Yaksh T. L., Dennis E. A., Inflammatory hyperalgesia induces essential bioactive lipid production in the spinal cord. Journal of Neurochemistry 2010 114 4 981 993 2-s2.0-77954751552 10.1111/j.1471-4159.2010.06815.x
11. Noguchi K., Okubo M., Leukotrienes in nociceptive pathway and neuropathic/inflammatory pain. Biological and Pharmaceutical Bulletin 2011 34 8 1163 1169 2-s2.0-80051527745 10.1248/bpb.34.1163
12. Dulin J. N., Karoly E. D., Wang Y., Strobel H. W., Grill R. J., Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury. The Journal of Neuroscience 2013 33 2 652 664 10.1523/JNEUROSCI.6128-11.2013
13. Mosser D. M., Edwards J. P., Exploring the full spectrum of macrophage activation. Nature Reviews Immunology 2008 8 12 958 969 2-s2.0-56749174940 10.1038/nri2448
14. Gautier E. L., Shay T., Miller J., Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nature Immunology 2012 13 1118 1128 10.1038/ni.2419
15. Kadl A., Meher A. K., Sharma P. R., Lee M. Y., Doran A. C., Johnstone S. R., Elliott M. R., Gruber F., Han J., Chen W., Kensler T., Ravichandran K. S., Isakson B. E., Wamhoff B. R., Leitinger N., Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circulation Research 2010 107 6 737 746 2-s2.0-77957260181 10.1161/CIRCRESAHA. 109.215715
16. Bogie J. F. J., Stinissen P., Hellings N., Hendriks J. J. A., Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation. Journal of Neuroinflammation 2011 8, article 85 2-s2.0-79960577501 10.1186/1742-2094-8-85
17. Gleissner C. A., Shaked I., Little K. M., Ley K., CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. Journal of Immunology 2010 184 9 4810 4818 2-s2.0-77954507872 10.4049/jimmunol.0901368
18. Gleissner C. A., Shaked I., Erbel C., Böckler D., Katus H. A., Ley K., CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circulation Research 2010 106 1 203 211 2-s2.0-74049100569 10.1161/CIRCRESAHA.109.199505
19. Sica A., Mantovani A., Macrophage plasticity and polarization: in vivo veritas. Journal of Clinical Investigation 2012 122 3 787 795 2-s2.0-84857883847 10.1172/JCI59643
20. Gensel J. C., Donnelly D. J., Popovich P. G., Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages. Expert Opinion on Therapeutic Targets 2011 15 4 505 518 2-s2.0-79952663518 10.1517/14728222.2011.553605
21. Shi C., Pamer E. G., Monocyte recruitment during infection and inflammation. Nature Reviews Immunology 2011 11 11 762 774 2-s2.0-80355146868 10.1038/nri3070
22. Geissmann F., Jung S., Littman D. R., Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003 19 1 71 82 2-s2.0-0037963473 10.1016/S1074-7613(03)00174-2 (Pubitemid 36859902)
23. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D. N., Leenen P. J. M., Liu Y.-J., MacPherson G., Randolph G. J., Scherberich J., Schmitz J., Shortman K., Sozzani S., Strobl H., Zembala M., Austyn J. M., Lutz M. B., Nomenclature of monocytes and dendritic cells in blood. Blood 2010 116 16 e74 e80 2-s2.0-77958185103 10.1182/blood-2010-02-258558
24. Yona S., Jung S., Monocytes: subsets, origins, fates and functions. Current Opinion in Hematology 2010 17 1 53 59 2-s2.0-73849152201 10.1097/MOH.0b013e3283324f80
25. Leuschner F., Dutta P., Gorbatov R., Novobrantseva T. I., Donahoe J. S., Courties G., Lee K. M., Kim J. I., Markmann J. F., Marinelli B., Panizzi P., Lee W. W., Iwamoto Y., Milstein S., Epstein-Barash H., Cantley W., Wong J., Cortez-Retamozo V., Newton A., Love K., Libby P., Pittet M. J., Swirski F. K., Koteliansky V., Langer R., Weissleder R., Anderson D. G., Nahrendorf M., Therapeutic siRNA silencing in inflammatory monocytes in mice. Nature Biotechnology 2011 29 11 1005 1010 2-s2.0-80155200721 10.1038/nbt.1989
26. Ransohoff R. M., Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology. Journal of Leukocyte Biology 1997 62 5 645 652 2-s2.0-0030669840 (Pubitemid 27519775)
27. Nahrendorf M., Swirski F. K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.-L., Libby P., Weissleder R., Pittet M. J., The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. Journal of Experimental Medicine 2007 204 12 3037 3047 2-s2.0-36549033197 10.1084/jem.20070885 (Pubitemid 350179569)
28. Mildner A., Schmidt H., Nitsche M., Merkler D., Hanisch U.-K., Mack M., Heikenwalder M., Brück W., Priller J., Prinz M., Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nature Neuroscience 2007 10 12 1544 1553 2-s2.0-36448955070 10.1038/nn2015 (Pubitemid 350175884)
29. Mahad D., Callahan M. K., Williams K. A., Ubogu E. E., Kivisäkk P., Tucky B., Kidd G., Kingsbury G. A., Chang A., Fox R. J., Mack M., Sniderman M. B., Ravid R., Staugaitis S. M., Stins M. F., Ransohoff R. M., Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain 2006 129 1 212 223 2-s2.0-30344481086 10.1093/brain/awh655 (Pubitemid 43063772)
30. Ricardo S. D., van Goor H., Eddy A. A., Macrophage diversity in renal injury and repair. Journal of Clinical Investigation 2008 118 11 3522 3530 2-s2.0-55849103960 10.1172/JCI36150
31. King I. L., Dickendesher T. L., Segal B. M., Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009 113 14 3190 3197 2-s2.0-65149093082 10.1182/blood-2008-07-168575
32. Thawer S., Mawhinney L., Chadwick K., Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the lys-egfp- ki mouse model. Journal of Neuroimmunology 2013 261 1 7 20 10.1016/j.jneuroim.2013.04.008
33. Shechter R., London A., Varol C., Raposo C., Cusimano M., Yovel G., Rolls A., Mack M., Pluchino S., Martino G., Jung S., Schwartz M., Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Medicine 2009 6 7 2-s2.0-68049143269 10.1371/journal.pmed.1000113 e1000113
34. Longbrake E. E., Lai W., Ankeny D. P., Popovich P. G., Characterization and modeling of monocyte-derived macrophages after spinal cord injury. Journal of Neurochemistry 2007 102 4 1083 1094 2-s2.0-34547428478 10.1111/j.1471-4159. 2007.04617.x (Pubitemid 47174229)
35. Mildner A., Schmidt H., Nitsche M., Merkler D., Hanisch U.-K., Mack M., Heikenwalder M., Brück W., Priller J., Prinz M., Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nature Neuroscience 2007 10 12 1544 1553 2-s2.0-36448955070 10.1038/nn2015 (Pubitemid 350175884)
36. King I. L., Dickendesher T. L., Segal B. M., Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009 113 14 3190 3197 2-s2.0-65149093082 10.1182/blood-2008-07-168575
37. Ma M., Wei T., Boring L., Charo I. F., Ransohoff R. M., Jakeman L. B., Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion. Journal of Neuroscience Research 2002 68 6 691 702 2-s2.0-0037097215 10.1002/jnr.10269 (Pubitemid 34594986)
38. Davies L. C., Rosas M., Smith P. J., Fraser D. J., Jones S. A., Taylor P. R., A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation. European Journal of Immunology 2011 41 8 2155 2164 2-s2.0-79960706327 10.1002/eji.201141817
39. Rosenfeld M. E., Ross R., Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1990 10 5 680 687 2-s2.0-0025063716 (Pubitemid 20273338)
40. Yang N., Isbel N. M., Nikolic-Paterson D. J., Li Y., Ye R., Atkins R. C., Lan H. Y., Local macrophage proliferation in human glomerulonephritis. Kidney International 1998 54 1 143 151 2-s2.0-0031862152 10.1046/j.1523-1755.1998. 00978.x (Pubitemid 28288028)
41. Xaus J., Comalada M., Valledor A. F., Cardó M., Herrero C., Soler C., Lloberas J., Celada A., Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. Immunobiology 2001 204 5 543 550 2-s2.0-0035710839 (Pubitemid 34134166)
42. Kigerl K. A., Gensel J. C., Ankeny D. P., Alexander J. K., Donnelly D. J., Popovich P. G., Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. The Journal of Neuroscience 2009 29 43 13435 13444 2-s2.0-70350558453 10.1523/JNEUROSCI.3257-09.2009
43. Chitu V., Stanley E. R., Colony-stimulating factor-1 in immunity and inflammation. Current Opinion in Immunology 2006 18 1 39 48 2-s2.0-30044448462 10.1016/j.coi.2005.11.006 (Pubitemid 43049646)
44. Hume D. A., MacDonald K. P. A., Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012 119 8 1810 1820 2-s2.0-84857618521 10.1182/blood-2011-09- 379214
45. O'Farrell A.-M., Liu Y., Moore K. W., Mui A. L.-F., IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. The EMBO Journal 1998 17 4 1006 1018 2-s2.0-0032481383 10.1093/emboj/17.4.1006 (Pubitemid 28077655)
46. O'Farrell A.-M., Parry D. A., Zindy F., Roussel M. F., Lees E., Moore K. W., Mui A. L.-F., Stat3-dependent induction of p19(INK4D) by IL-10 contributes to inhibition of macrophage proliferation. Journal of Immunology 2000 164 9 4607 4615 2-s2.0-0034193958 (Pubitemid 30238059)
47. Arpa L., Valledor A. F., Lloberas J., Celada A., IL-4 blocks M-CSF-dependent macrophage proliferation by inducing p21waf1 in a STAT6-dependent way. European Journal of Immunology 2009 39 2 514 526 2-s2.0-60749122610 10.1002/eji.200838283
48. Pascual-García M., Carbó J. M., León T., Matalonga J., Out R., Berkel T. V., Sarrias M.-R., Lozano F., Celada A., Valledor A. F., Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4. Journal of Immunology 2011 186 8 4656 4667 2-s2.0-79955030449 10.4049/jimmunol.1000585
49. Hong C., Tontonoz P., Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Current Opinion in Genetics and Development 2008 18 5 461 467 2-s2.0-56249140398 10.1016/j.gde.2008.07.016 (Pubitemid 50280209)
50. Wynn T. A., Chawla A., Pollard J. W., Macrophage biology in development, homeostasis and disease. Nature 2013 496 445 455 10.1038/nature12034
51. Boissonneault V., Filali M., Lessard M., Relton J., Wong G., Rivest S., Powerful beneficial effects of macrophage colony-stimulating factor on β -amyloid deposition and cognitive impairment in Alzheimers disease. Brain 2009 132 4 1078 1092 2-s2.0-65249119363 10.1093/brain/awn331
52. Yagihashi A., Sekiya T., Suzuki S., Macrophage colony stimulating factor (M-CSF) protects spiral ganglion neurons following auditory nerve injury: morphological and functional evidence. Experimental Neurology 2005 192 1 167 177 2-s2.0-13444301356 10.1016/j.expneurol.2004.10.020 (Pubitemid 40208550)
53. Berezovskaya O., Maysinger D., Fedoroff S., Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion. Acta Neuropathologica 1996 92 5 479 486 2-s2.0-0029972157 10.1007/s004010050550 (Pubitemid 26356539)
54. 2+ permeable AMPA receptors into adult motor neurons and enhances their susceptibility to slow excitotoxic injury. Experimental Neurology 2012 238 93 102 10.1016/j.expneurol.2012.08.004
55. Neumann H., Schweigreiter R., Yamashita T., Rosenkranz K., Wekerle H., Barde Y.-A., Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a Rho-dependent mechanism. The Journal of Neuroscience 2002 22 3 854 862 2-s2.0-0036469263 (Pubitemid 34141766)
56. Sharma A., Sharma H. S., Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair. International Review of Neurobiology 2012 102 23 45 10.1016/B978-0-12-386986-9.00002-8
57. Pineau I., Lacroix S., Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. Journal of Comparative Neurology 2007 500 2 267 285 2-s2.0-33845568271 10.1002/cne.21149 (Pubitemid 44937122)
58. Sullivan P. G., Bruce-Keller A. J., Rabchevsky A. G., Christakos S., St. Clair D. K., Mattson M. P., Schelf S. W., Exacerbation of damage and altered NF- B activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. The Journal of Neuroscience 1999 19 15 6248 6256 2-s2.0-0033178340 (Pubitemid 29347425)
59. Esposito E., Cuzzocrea S., Anti-TNF therapy in the injured spinal cord. Trends in Pharmacological Sciences 2011 32 2 107 115 2-s2.0-79651468735 10.1016/j.tips.2010.11.009
60. Huie J. R., Baumbauer K. M., Lee K. H., Glial tumor necrosis factor alpha (TNFalpha) generates metaplastic inhibition of spinal learning. PLoS One 2012 7 e39751
61. Vidal P. M., Lemmens E., Geboes L., Late blocking of peripheral TNF-alpha is ineffective after spinal cord injury in mice. Immunobiology 2013 218 281 284 10.1016/j.imbio.2012.05.007
62. Genovese T., Mazzon E., Crisafulli C., Di Paola R., Muià C., Esposito E., Bramanti P., Cuzzocrea S., TNF- α blockage in a mouse model of SCI: evidence for improved outcome. Shock 2008 29 1 32 41 2-s2.0-37549029154 10.1097/shk.0b013e318059053a
63. Wang X., Luo C., Li W., Effect of infliximab combined with methylprednisolone on expressions of NF-kappaB, TRADD and FADD in rat acute spinal cord injury. Spine 2013 38 14 E861 E8E9 10.1097/BRS.0b013e318294892c
64. Chen K.-B., Uchida K., Nakajima H., Yayama T., Hirai T., Watanabe S., Guerrero A. R., Kobayashi S., Ma W.-Y., Liu S.-Y., Baba H., Tumor necrosis factor- α antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine 2011 36 17 1350 1358 2-s2.0-80051522971 10.1097/BRS.0b013e3181f014ec
65. Bordet R., Ouk T., Petrault O., Gelé P., Gautier S., Laprais M., Deplanque D., Duriez P., Staels B., Fruchart J. C., Bastide M., PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochemical Society Transactions 2006 34 6 1341 1346 2-s2.0-34147182536 10.1042/BST0341341 (Pubitemid 46769051)
66. Kliewer S. A., Lenhard J. M., Willson T. M., Patel I., Morris D. C., Lehmann J. M., A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 1995 83 5 813 819 2-s2.0-0028972026 (Pubitemid 3006325)
67. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M., 15-deoxy-Δ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ Cell 1995 83 5 803 812 2-s2.0-0028972025 (Pubitemid 3006324)
68. Chawla A., Control of macrophage activation and function by PPARs. Circulation Research 2010 106 10 1559 1569 2-s2.0-77952997178 10.1161/CIRCRESAHA.110.216523
69. Bouhlel M. A., Derudas B., Rigamonti E., Dièvart R., Brozek J., Haulon S., Zawadzki C., Jude B., Torpier G., Marx N., Staels B., Chinetti-Gbaguidi G., PPAR γ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metabolism 2007 6 2 137 143 2-s2.0-34547492488 10.1016/j.cmet.2007.06.010 (Pubitemid 47189091)
70. Yonutas H. M., Sullivan P. G., Targeting PPAR isoforms following CNS injury. Current Drug Targets 2013 14 733 742 10.2174/1389450111314070003
71. Zhao Y., Patzer A., Herdegen T., Gohlke P., Culman J., Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. The FASEB Journal 2006 20 8 1162 1175 2-s2.0-33745983234 10.1096/fj.05-5007com (Pubitemid 44943912)
72. Pereira M. P., Hurtado O., Cárdenas A., Boscá L., Castillo J., Dávalos A., Vivancos J., Serena J., Lorenzo P., Lizasoain I., Moro M. A., Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J 2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. Journal of Cerebral Blood Flow and Metabolism 2006 26 2 218 229 2-s2.0-31444445868 10.1038/sj.jcbfm.9600182 (Pubitemid 43151578)
73. Park S.-W., Yi J.-H., Miranpuri G., Satriotomo I., Bowen K., Resnick D. K., Vemuganti R., Thiazolidinedione class of peroxisome proliferator-activated receptor γ agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. Journal of Pharmacology and Experimental Therapeutics 2007 320 3 1002 1012 2-s2.0-33847093475 10.1124/jpet.106.113472 (Pubitemid 46294061)
74. McTigue D. M., Tripathi R., Wei P., Lash A. T., The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury. Experimental Neurology 2007 205 2 396 406 2-s2.0-34248598448 10.1016/j.expneurol.2007.02.009 (Pubitemid 46755761)
75. Hyong A., Jadhav V., Lee S., Tong W., Rowe J., Zhang J. H., Tang J., Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents. Brain Research 2008 1215 218 224 2-s2.0-44649087641 10.1016/j.brainres.2008.04.025
76. Zhao X., Zhang Y., Strong R., Grotta J. C., Aronowski J., 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor- γ promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. Journal of Cerebral Blood Flow and Metabolism 2006 26 6 811 820 2-s2.0-33745684630 10.1038/sj.jcbfm.9600233
77. Ou Z., Zhao X., Labiche L. A., Strong R., Grotta J. C., Herrmann O., Aronowski J., Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPAR γ) and 15d-prostaglandin J2-mediated protection of brain after experimental cerebral ischemia in rat. Brain Research 2006 1096 1 196 203 2-s2.0-33745264383 10.1016/j.brainres.2006.04.062 (Pubitemid 43928925)
78. Diab A., Deng C., Smith J. D., Hussain R. Z., Phanavanh B., Lovett-Racke A. E., Drew P. D., Racke M. K., Peroxisome proliferator-activated receptor- γ agonist 15-deoxy-Δ12,14-prostaglandin J2 ameliorates experimental autoimmune encephalomyelitis. Journal of Immunology 2002 168 5 2508 2515 2-s2.0-0036499074 (Pubitemid 34171857)
79. Kwon B. K., Okon E., Hillyer J., Mann C., Baptiste D., Weaver L. C., Fehlings M. G., Tetzlaff W., A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. Journal of Neurotrauma 2011 28 8 1545 1588 2-s2.0-79960764840 10.1089/neu.2009.1149
80. Zhang Q.-Z., Su W.-R., Shi S.-H., Wilder-Smith P., Xiang A. P., Wong A., Nguyen A. L., Kwon C. W., Le A. D., Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing. Stem Cells 2010 28 10 1856 1868 2-s2.0-78149335954 10.1002/stem.503
81. Spaggiari G. M., Moretta L., Cellular and molecular interactions of mesenchymal stem cells in innate immunity. Immunology and Cell Biology 2013 91 27 31 10.1038/icb.2012.62
82. Kim J., Hematti P., Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Experimental Hematology 2009 37 12 1445 1453 2-s2.0-70449527554 10.1016/j.exphem.2009.09.004
83. Li M., Ikehara S., Bone-marrow-derived mesenchymal stem cells for organ repair. Stem Cells International 2013 2013 8 132642 10.1155/2013/132642
84. Greish S., Abogresha N., Abdel-Hady Z., Zakaria E., Ghaly M., Hefny M., Human umbilical cord mesenchymal stem cells as treatment of adjuvant rheumatoid arthritis in a rat model. World Journal of Stem Cells 2012 4 101 109 10.4252/wjsc.v4.i10.101
85. Wang M., Yang Y., Yang D., Luo F., Liang W., Guo S., Xu J., The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 2009 126 2 220 232 2-s2.0-58149316095 10.1111/j.1365-2567.2008.02891.x
86. Kim J. W., Ha K. Y., Molon J. N., Kim Y. H., Bone marrow derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation. Spine 2013 38 17 E1065 E1074 10.1097/BRS.0b013e31829839fa
87. Boido M., Garbossa D., Fontanella M., Ducati A., Vercelli A., Mesenchymal Stem Cell Transplantation Reduces Glial Cyst and Improves Functional Outcome After Spinal Cord Compression. World Neurosurgy 2012 10.1016/j.wneu.2012.08.014
88. Quertainmont R., Cantinieaux D., Botman O., Selim Sid, Schoenen J., Franzen R., Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One 2012 7 e39500 10.1371/journal.pone.0039500
89. Park S. I., Lim J. Y., Jeong C. H., Kim S. M., Jun J. A., Jeun S.-S., Il Oh W., Human umbilical cord blood-derived mesenchymal stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell proliferation and oligogenesis. Journal of Biomedicine and Biotechnology 2012 2012 8 2-s2.0-84858124183 10.1155/2012/362473 362473
90. Nakajima H., Uchida K., Guerrero A. R., Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. Journal of Neurotrauma 2012 29 1614 1625 10.1089/neu.2011.2109
91. Nishimura S., Yasuda A., Iwai H., Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury. Molecular Brain 2013 6, article 3
92. Parr A. M., Kulbatski I., Tator C. H., Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury. Journal of Neurotrauma 2007 24 5 835 845 2-s2.0-34249039544 10.1089/neu.2006.3771 (Pubitemid 46799275)
93. Karimi-Abdolrezaee S., Eftekharpour E., Wang J., Morshead C. M., Fehlings M. G., Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. The Journal of Neuroscience 2006 26 13 3377 3389 2-s2.0-33645455547 10.1523/JNEUROSCI.4184-05.2006
94. Guerrero A. R., Uchida K., Nakajima H., Watanabe S., Nakamura M., Johnson W. E. B., Baba H., Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. Journal of Neuroinflammation 2012 9, article 40 2-s2.0-84858861533 10.1186/1742-2094-9-40
95. Guo Y., Zhang H., Yang J., Granulocyte colony-stimulating factor improves alternative activation of microglia under microenvironment of spinal cord injury. Neuroscience 2013 238 1 10 10.1016/j.neuroscience.2013.01.047
96. Jiang M. H., Chung E., Chi G. F., Substance P induces M2-type macrophages after spinal cord injury. Neuroreport 2012 23 13 786 792 10.1097/WNR. 0b013e3283572206
97. Bracken M. B., Steroids for acute spinal cord injury. Cochrane Database of Systematic Reviews 2002 1 10.1002/14651858.CD001046.pub2. CD001046
98. Schwartz M., 'Tissue-repairing' blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells? Brain, Behavior, and Immunity 2010 24 7 1054 1057 2-s2.0-77956471996 10.1016/j.bbi.2010.01.010
99. Bomstein Y., Marder J. B., Vitner K., Smirnov I., Lisaey G., Butovsky O., Fulga V., Yoles E., Features of skin-coincubated macrophages that promote recovery from spinal cord injury. Journal of Neuroimmunology 2003 142 1-2 10 16 2-s2.0-0642309623 10.1016/S0165-5728(03)00260-1 (Pubitemid 38368584)
100. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G. J., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M., Hadani M., Schwartz M., Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nature Medicine 1998 4 7 814 821 2-s2.0-0031849511 10.1038/nm0798-814 (Pubitemid 28331023)
101. Shechter R., Miller O., Yovel G., Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 2013 38 3 555 569 10.1016/j.immuni.2013.02.012
102. Klopstein A., Santos-Nogueira E., Francos-Quijorna I., Beneficial effects of α β -crystallin in spinal cord contusion injury. The The Journal of Neuroscience 2012 32 42 14478 14488 10.1523/JNEUROSCI.0923-12.2012
103. van Noort J., Bsibsi M., Nacken P., Activation of an immune-regulatory macrophage response and inhibition of lung inflammation in a mouse model of COPD using heat-shock protein alpha B-crystallin-loaded PLGA microparticles. Biomaterials 2013 34 3 831 840 10.1016/j.biomaterials.2012.10.028
104. Fleming B. D., Mosser D. M., Regulatory macrophages: setting the threshold for therapy. European Journal of Immunology 2011 41 9 2498 2502 2-s2.0-80052180187 10.1002/eji.201141717
105. Edwards J. P., Zhang X., Frauwirth K. A., Mosser D. M., Biochemical and functional characterization of three activated macrophage populations. Journal of Leukocyte Biology 2006 80 6 1298 1307 2-s2.0-33845398215 10.1189/jlb.0406249 (Pubitemid 44904968)
106. Mestas J., Hughes C. C. W., Of Mice and Not Men: differences between Mouse and Human Immunology. Journal of Immunology 2004 172 5 2731 2738 2-s2.0-1342303482 (Pubitemid 38263654)
107. Martinez F. O., Gordon S., Locati M., Mantovani A., Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. Journal of Immunology 2006 177 10 7303 7311 2-s2.0-33750813483 (Pubitemid 44715100)
108. Yona S., Kim -W K., Wolf Y., Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013 38 1 79 91 10.1016/j.immuni.2012.12.001
109. Terry R. L., Getts D. R., Deffrasnes C., van Vreden C., Campbell I. L., King N. J. C., Inflammatory monocytes and the pathogenesis of viral encephalitis. Journal of Neuroinflammation 2012 9, article 270 10.1186/1742-2094-9-270
110. Sunderkötter C., Nikolic T., Dillon M. J., van Rooijen N., Stehling M., Drevets D. A., Leenen P. J. M., Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. Journal of Immunology 2004 172 7 4410 4417 2-s2.0-1642406217 (Pubitemid 38375256)
111. David S., Kroner A., Repertoire of microglial and macrophage responses after spinal cord injury. Nature Reviews Neuroscience 2011 12 7 388 399 2-s2.0-79959379095 10.1038/nrn3053